The FDA has given clearance to Siemens Healthineers' RapidPoint 500e blood gas analyzer, used to monitor and diagnose patients who are critically ill. The device may be used to monitor respiratory distress in COVID-19 patients.
A self-administered coronavirus test will be launched by UnitedHealth Group to help reduce the exposure risk of health care providers. A study found the swab tests accurately detected the virus in more than 90% of positive patients.
Bluebird bio said the trials of its LentiGlobin gene therapy for beta thalassemia as well as applications with the FDA will have to be deferred due to the COVID-19 pandemic. Commercial launch of the therapy is also being delayed in Europe, where it has been approved under the name Zynteglo.
Laboratory managers should understand and be involved in their laboratories' finances to be seen as a profit center instead of a cost center, says Visiun President and CEO Thomas Joseph. Lab managers need to demonstrate value to hospital leaders as hospitals increasingly outsource or sell outreach programs, says Jane Hermansen, director of Mayo Clinic Laboratories' outreach consulting program.
The FDA granted emergency use authorization to Abbott's ID NOW COVID-19 test, which can deliver positive results in five minutes and negative results in 13. The portable test is small enough that it can be used in most health care settings, and Abbott said it expects to manufacture about 5 million tests per month and deliver 50,000 tests per day starting this week.
Researchers analyzed CT and X-ray images and reverse transcription polymerase chain reaction test results of 33 newborns from mothers with COVID-19 pneumonia and found that three of the babies were diagnosed with the infection. The findings, published in JAMA Pediatrics, highlighted the importance of screening pregnant women and implementing strict infection control strategies, close monitoring of newborns at risk for the illness and quarantining infected mothers, study authors wrote.
AlloVir and the Baylor College of Medicine will collaborate to develop a virus-specific allogeneic T-cell therapy for COVID-19. The T-cell therapy could be incorporated into AlloVir's investigational therapy ALVR106 or developed as a stand-alone treatment.
The HHS Office of Inspector General issued an alert urging Medicare recipients to be wary of fraudulent schemes preying on fears of COVID-19. The agency said some scams, which may be carried out through social media, telemarketing or door-to-door, have involved offers of coronavirus tests in exchange for personal information.
- Page 1